This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Asthma Control Questionnaire (ACQ)

Authoring team

ACQ includes response to 7 questions, 5 relating to symptoms, 1 rescue symptom use and 1 FEV1.

  • is well validated in adults and children older than 5 years
  • response usually assessed over the preceding week
  • a 7-point scale (0 = no impairment, 6 = maximum impairment) is used for each question and the ACQ score is the mean value of the 7 questions - hence between 0 (totally controlled) and 6 (severely uncontrolled)
  • generally a score below 1.0 is considered to have an adequately controlled asthma while a score of above 1.0 is considered to be not well controlled
  • however patients with score between 0.75 and 1.25 is considered to be on the borderline of adequate control
  • a change or difference in score of 0.5 or greater should prompt the clinician to change the patient’s treatment although this may differ among individual patients (2)

A shortened, five question symptom only questionnaire is just as valid and is probably best for those with normal or near normal FEV1 (1)

Further information on ACQ and other questionnaires on asthma can be found on “Measurement of Health-Related Quality of Life & Asthma Control” website (2).

References:

  1. British Thoracic Society (BTS)/SIGN 2019. British Guideline on the Management of Asthma. A national clinical guideline.
  2. Measurement of Health-Related Quality of Life & Asthma Control.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.